CoChat

Argentatin B Inhibits Proliferation of Prostate and Colon Cancer Cells by Inducing Cell Senescence

Open access
Alcántara-Flores, Ela, Brechú-Franco, Alicia, García-López, Patricia, Rocha-Zavaleta, Leticia, López-Marure, Rebeca, Martínez-Vázquez, Mariano · 2015 · Molecules

The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.

Abstract

Argentatin B has been shown to inhibit the growth of colon HCT-15, and prostate PC-3 cancer cells. However, the mechanism by which argentatin B inhibits cell proliferation is still unknown. We aimed to investigate the mechanism by which argentatin B inhibits cell proliferation. The cell cycle was studied by flow cytometry. Apoptosis was evaluated by Annexin-V-Fluos, and Hoechst 33342 dye staining. Cell senescence was evaluated by proliferation tests, and staining for SA-β-galactosidase. Senescence-related proteins (PCNA, p21, and p27) were analyzed by Western blotting. Potential toxicity of argentatin B was evaluated in CD-1 mice. Its effect on tumor growth was tested in a HCT-15 and PC-3 xenograft model. Argentatin B induced an increment of cells in sub G1, but did not produce apoptosis. Proliferation of both cell lines was inhibited by argentatin B. Forty-three percent HCT-15, and 66% PC-3 cells showed positive SA-β-galactosidase staining. The expression of PCNA was decreased, p21 expression was increased in both cell lines, but p27 expression increased only in PC-3 cells after treatment. Administration of argentatin B to healthy mice did not produce treatment-associated pathologies. However, it restricted the growth of HCT-15 and PC-3 tumors. These results indicate that treatment with argentatin B induces cell senescence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules201219757

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemical structure of argentatin B (16β, 24R-16,24-epoxi-25-hidroxicicloartan-3-one).
Figure 1 Chemical structure of argentatin B (16β, 24R-16,24-epoxi-25-hidroxicicloartan-3-one).CC BY · PubMed Central
Figure 2 Effect of argentatin B on cell cycle progression. HCT-15 (A) and PC-3 (B) cells were incubated with 24 μM or 34 μM argentatin B, respectively, for 48 and 72 h. As a positive control cells were treated with cisplatin 14 μM. Negative control cultures received the carrier solvent (0.2% DMSO). The cells were stained with propidium iodide, and the cell cycle distribution was analyzed by flow cytometry using the BD CellQuest Pro Software. Data represent the average of three independent assays. Error bars indicate the standard error of the mean. * p < 0.05, ** p < 0.001, and *** p < 0.0001 vs. vehicle (one-way ANOVA test, and Tukey-Kramer post-test).
Figure 2 Effect of argentatin B on cell cycle progression. HCT-15 (A) and PC-3 (B) cells were incubated with 24 μM or 34 μM argentatin B, respectively, for 48 and 72 h. As a positive control cells were treated with cisplatin 14 μM. Negative control cultures received the carrier solvent (0.2% DMSO). The cells were stained with propidium iodide, and the cell cycle distribution was analyzed by flow cytometry using the BD CellQuest Pro Software. Data represent the average of three independent assays. Error bars indicate the standard error of the mean. * p < 0.05, ** p < 0.001, and *** p < 0.0001 vs. vehicle (one-way ANOVA test, and Tukey-Kramer post-test).CC BY · PubMed Central
Figure 3 Effect of argentatin B on cell death. HCT-15 (A); and PC-3 (B) cells were incubated with argentatin B (arg B) for 48 h and 72 h. Cell death was analyzed by labelling with Annexin V and Propidum Iodide (PI). The number of apoptotic and necrotic cells was evaluated by flow cytometry (upper panel). The proportion of viable cells, showing negative annexin and PI staining is depicted in the left lower quadrant. Apoptotic cells, positive annexin, are shown in the right lower quadrant. Necrotic cells, positive annexin and PI staining, are presented in the right upper quadrant. Results are representative figures from three independent tests. Cells stained with Annexin, PI, and Hoechst were also analyzed by fluorescence microscopy (lower panel). Figures are representative micrographs from three independent experiments.
Figure 3 Effect of argentatin B on cell death. HCT-15 (A); and PC-3 (B) cells were incubated with argentatin B (arg B) for 48 h and 72 h. Cell death was analyzed by labelling with Annexin V and Propidum Iodide (PI). The number of apoptotic and necrotic cells was evaluated by flow cytometry (upper panel). The proportion of viable cells, showing negative annexin and PI staining is depicted in the left lower quadrant. Apoptotic cells, positive annexin, are shown in the right lower quadrant. Necrotic cells, positive annexin and PI staining, are presented in the right upper quadrant. Results are representative figures from three independent tests. Cells stained with Annexin, PI, and Hoechst were also analyzed by fluorescence microscopy (lower panel). Figures are representative micrographs from three independent experiments.CC BY · PubMed Central
Figure 4 Argentatin B induces cell senescence at 72 h. (A) Representative micrographs of HCT-15 and PC-3 treated with argentatin B or vehicle (Magnification, ×40); (B) SA-β-gal-positive cells were evaluated by counting more than 100 cells for each treatment. Values presented are the mean of three independent experiments. Error bars indicate the standard error of the mean. ** p < 0.001, and *** p < 0.0001 vs. vehicle (one-way ANOVA test, and Tukey-Kramer post-test)
Figure 4 Argentatin B induces cell senescence at 72 h. (A) Representative micrographs of HCT-15 and PC-3 treated with argentatin B or vehicle (Magnification, ×40); (B) SA-β-gal-positive cells were evaluated by counting more than 100 cells for each treatment. Values presented are the mean of three independent experiments. Error bars indicate the standard error of the mean. ** p < 0.001, and *** p < 0.0001 vs. vehicle (one-way ANOVA test, and Tukey-Kramer post-test)CC BY · PubMed Central
Figure 5 Argentatin B inhibits cell proliferation and increases expression of senescence-associated proteins. HCT-15 (A), and PC-3 (B) cells were treated with the indicated concentrations of argentatin B for 48 h. Cell numbers were evaluated by using the colorimetric MTT assay. Values presented are the mean of three independent experiments. Error bars indicate the standard error of the mean. * p < 0.05, vs. the number of cells seeded at the beginning of the experiment (initial number of cells) (one-way ANOVA test, and Tukey-Kramer post-test); (C) Western blot analysis of the expression of the proliferation marker PCNA. HCT-15, and PC-3 were incubated with 24 μM or 34 μM argentatin B, respectively for 24, 48, and 72 h. Detection of GAPDH was included as an internal control; (D) Western blot analysis of the expression of negative cell cycle regulators p21 and p27 in response to argentatin. HCT-15 and PC-3 cells were incubated with 24 μM or 34 μM argentatin B, respectively for 24, 48, and 72 h. Detection of GAPDH was included as an internal control.
Figure 5 Argentatin B inhibits cell proliferation and increases expression of senescence-associated proteins. HCT-15 (A), and PC-3 (B) cells were treated with the indicated concentrations of argentatin B for 48 h. Cell numbers were evaluated by using the colorimetric MTT assay. Values presented are the mean of three independent experiments. Error bars indicate the standard error of the mean. * p < 0.05, vs. the number of cells seeded at the beginning of the experiment (initial number of cells) (one-way ANOVA test, and Tukey-Kramer post-test); (C) Western blot analysis of the expression of the proliferation marker PCNA. HCT-15, and PC-3 were incubated with 24 μM or 34 μM argentatin B, respectively for 24, 48, and 72 h. Detection of GAPDH was included as an internal control; (D) Western blot analysis of the expression of negative cell cycle regulators p21 and p27 in response to argentatin. HCT-15 and PC-3 cells were incubated with 24 μM or 34 μM argentatin B, respectively for 24, 48, and 72 h. Detection of GAPDH was included as an internal control.CC BY · PubMed Central
Figure 6 Evaluation of effects of argentatin B in vivo. Antitumor activity of argentatin B was evaluated in nu/nu mice implanted with HCT-15 (A) and PC3 (B) cells. Mice received the indicated concentrations of argentatin B, cisplatin or sesame oil (vehicle) at days 0, 7, and 14. Each point represents the average ± SEM of six animals. Significant differences of * p < 0.05, ** p < 0.001, and *** p < 0.0001 vs. vehicle are shown (one-way ANOVA test, and Tukey-Kramer post-test); (C) Evaluation of body weight change in nu/nu mice; (D) The toxicity of argentatin B was tested in groups of three CD-1 mice. The indicated doses of argentatin B, cisplatin or vehicle were administered intraperitoneally every week. The weight of the mice was recorded every other day. Error bars indicate the standard error of the mean.
Figure 6 Evaluation of effects of argentatin B in vivo. Antitumor activity of argentatin B was evaluated in nu/nu mice implanted with HCT-15 (A) and PC3 (B) cells. Mice received the indicated concentrations of argentatin B, cisplatin or sesame oil (vehicle) at days 0, 7, and 14. Each point represents the average ± SEM of six animals. Significant differences of * p < 0.05, ** p < 0.001, and *** p < 0.0001 vs. vehicle are shown (one-way ANOVA test, and Tukey-Kramer post-test); (C) Evaluation of body weight change in nu/nu mice; (D) The toxicity of argentatin B was tested in groups of three CD-1 mice. The indicated doses of argentatin B, cisplatin or vehicle were administered intraperitoneally every week. The weight of the mice was recorded every other day. Error bars indicate the standard error of the mean.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Ortega, 1970, Determinación de las estructuras de las argentatinas A, B y C del guayule, Rev. Latinoam. Quim., 1, 24
  2. Calzada, 1995, Effect of tetracyclic triterpenes (argentatins A, B and D) on the estradiol receptor of hormone-dependent tumours of human breast, Med. Sci. Res., 23, 815

Cited by

Metadata

Authors
Alcántara-Flores, E., Brechú-Franco, A., García-López, P., Rocha-Zavaleta, L., López-Marure, R., & Martínez-Vázquez, M.
Affiliations
  • Universidad Nacional Autónoma de México (MX)
  • Instituto Nacional de Cancerología, Subdirección de Investigación Básica, Tlalpan, C.P. 14080, México D.F., Mexico
  • Instituto de Investigaciones Biomédicas, Departamento de Biología Molecular y Biotecnología, Universidad Nacional Autónoma de México, Circuito Escolar s/n, Coyoacán, C.P. 04510, México, D.F., Mexico
  • Instituto Nacional de Cardiología “Ignacio Chávez”, Departamento de Biología Celular, Juan Badiano No. 1, Colonia Sección 16, Tlalpan, C.P. 14080, México D.F., Mexico
  • Instituto de Química, Departamento de Productos Naturales, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán, C.P. 04510, México D.F., Mexico
Venue
Molecules
Publisher
MDPI AG
Published
2015-11-27
Volume
20
Issue
12
Pages
21125-21137
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2174443992
Cited by
17
References
32
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2017: 1
FWCI
0.25
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Consejo Nacional de Ciencia y Tecnología (152650)
  • Directorate for Biological Sciences
  • Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
cellular senescence, prostate cancer, colon cancer, cell proliferation inhibition, PC-3 cells, HCT-15 cells, SA-β-galactosidase, p21, p27, PCNA, sub-G1 cell cycle arrest, xenograft tumor growth, cytotoxicity
MeSH terms
Animals, Cell Cycle, Colonic Neoplasms, Flow Cytometry, Humans, Male, Mice, Nude, Prostatic Neoplasms, Triterpenes, Tumor Cells, Cultured, Blotting, Western, Cellular Senescence, Apoptosis, Xenograft Model Antitumor Assays, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.